Pacemaker Therapy After Tricuspid Valve Operations: Implications on Mortality, Morbidity, and Quality of Life Janne J. Jokinen, MD, Anu K. Turpeinen,

Slides:

Advertisements

Similar presentations

Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,

Advertisements

Serum C-Reactive Protein as a Predictor of Morbidity and Mortality in Intensive Care Unit Patients After Esophagectomy Michel E. van Genderen, BS, Alexandre.

Severity of Angina as a Predictor of Quality of Life Changes Six Months After Coronary Artery Bypass Surgery Vladan M. Peric, MD, Milorad D. Borzanovic,

Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Neonatal Flail Tricuspid Valve: Diagnosis and Management

Reply The Annals of Thoracic Surgery

Jason O. Robertson, MD, Phillip S. Cuculich, MD, Lindsey L

Constantin Stefanidis, MD, Albert M

Niv Ad, MD, Linda Henry, PhD, Sharon Hunt, MBA, Sari D. Holmes, PhD

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Homograft Implantation Techniques in the Aortic Position: To Preserve or Replace the Aortic Root? Thanos Athanasiou, MD, PhD, Catherine Jones, MBBS,

Society of Thoracic Surgeons Score Is Superior to the EuroSCORE Determining Mortality in High Risk Patients Undergoing Isolated Aortic Valve Replacement

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Eleven-Year Single-Center Experience with the ATS Open Pivot Bileaflet Heart Valve Doan Baykut, MD, Leticia Grize, PhD, Christian Schindler, PhD, Angelika.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M

The Effect of Institutional Volume on Complications and Their Impact on Mortality After Pediatric Heart Transplantation Cecillia Lui, MD, Joshua C. Grimm,

Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,

Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.

Chronic Atrial Fibrillation Is Associated With Reduced Survival After Aortic and Double Valve Replacement Richard Schulenberg, MD, Polychronis Antonitsis,

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Long-Term Follow-Up After Thoracoabdominal Aortic Aneurysm Repair

Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,

Gender Differences in Long-Term Survival of Medicare Beneficiaries Undergoing Mitral Valve Operations Christina M. Vassileva, MD, Christian McNeely,

Outcome of Concomitant Cox-Maze III Procedure Using an Argon-Based Cryosurgical System: A Single-Center Experience With 250 Patients Bobby Yanagawa,

Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation Joshua C. Grimm, MD, Christopher.

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Laila Hellgren, MD, Elisabeth Ståhle, MD, PhD

Expanding Indications for Valve-Sparing Aortic Root Reconstruction: Early and Midterm Results Johanna Valo, BM, Janne J. Jokinen, MD, PhD, Markku Kaarne,

Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting

Robert J. Moraca, MD, Marc R. Moon, MD, Jennifer S

Zain Khalpey, MD, PhD, Wernard Borstlap, Patrick O. Myers, MD, Jan D

Serum C-Reactive Protein as a Predictor of Morbidity and Mortality in Intensive Care Unit Patients After Esophagectomy Michel E. van Genderen, BS, Alexandre.

David P. Mason, MD, Dale H. Marsh, MD, Joan M. Alster, MS, Sudish C

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality Edward L. Hannan, PhD, Zaza Samadashvili,

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Kevin L. Greason, MD, Brian D. Lahr, MS, John M

Robert H. Habib, PhD, Thomas A. Schwann, MD, Milo Engoren, MD

James W.W. Wong, MD, Koon-Hou Mak, MD, FACC

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Surgical Treatment of Aortic Prosthetic Valve Endocarditis: A 20-Year Single-Center Experience Sossio Perrotta, MD, Anders Jeppsson, MD, PhD, Victoria.

Aaron J. Lindsay, MD, Meng Xu, MS, Daniel I. Sessler, MD, Eugene H

Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD

Impact of Functional Status on Survival After Coronary Artery Bypass Grafting in a Veteran Population Roberto Cervera, MD, Faisal G. Bakaeen, MD, Lorraine.

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Age at Repair Affects the Very Long-Term Outcome of Sinus Venosus Defect Giovanni Battista Luciani, MD, Francesca Viscardi, MD, Mara Pilati, MD, Roberto.

Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?

Twenty-Five Year Outcomes of Tricuspid Valve Replacement Comparing Mechanical and Biologic Prostheses Andrea Garatti, MD, Giovanni Nano, MD, Giuseppe.

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Ventricular Pacing Through Coronary Sinus in Patients With Tricuspid Prosthesis Caroline Grimard, MD, Nicolas Clémenty, MD, Laurent Fauchier, MD, PhD,

“Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

The Risk and Outcomes of Reoperative Tricuspid Valve Surgery

Mark W. Hennon, MD, Elisabeth U

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

John M. Stulak, MD, Harold M. Burkhart, MD, Joseph A

Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Heinrich Koertke, MD,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Risk of Valve-Related Events After Aortic Valve Repair

Presentation transcript:

Pacemaker Therapy After Tricuspid Valve Operations: Implications on Mortality, Morbidity, and Quality of Life Janne J. Jokinen, MD, Anu K. Turpeinen, MD, PhD, Otto Pitkänen, MD, PhD, Mikko J. Hippeläinen, MD, PhD, Juha E.K. Hartikainen, MD, PhD The Annals of Thoracic Surgery Volume 87, Issue 6, Pages 1806-1814 (June 2009) DOI: 10.1016/j.athoracsur.2009.03.048 Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Incidence of a new permanent pacemaker implantation during long-term follow-up. The Annals of Thoracic Surgery 2009 87, 1806-1814DOI: (10.1016/j.athoracsur.2009.03.048) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival of study group (solid line) vs age- and sex-matched reference population. Parallel gray lines indicate 95% confidence intervals for the reference population (***) survival. The Annals of Thoracic Surgery 2009 87, 1806-1814DOI: (10.1016/j.athoracsur.2009.03.048) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Survival curves of the patients who needed a pacemaker (PM +, solid line) and those who did not (PM−, dashed line). Early mortality (deaths within 30 days after the operation) is excluded. The Annals of Thoracic Surgery 2009 87, 1806-1814DOI: (10.1016/j.athoracsur.2009.03.048) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 The Nottingham Health Profile (NHP) quality of life (QOL) analysis for patients who required a pacemaker (PM+ up-slant bars) compared with those who did not (PM−, down-slant bars), all patients (black bars), and a reference population (dotted bars). Significances: *p < 0.05, **p < 0.01, ***p < 0.001. Error bars indicate 95% confidence intervals. The Annals of Thoracic Surgery 2009 87, 1806-1814DOI: (10.1016/j.athoracsur.2009.03.048) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions